Advances in the use of stem cell transplants in the treatment of multiple sclerosis.
作者信息
Thomas Rachel, Wynford-Thomas Ray, Robertson Neil P
机构信息
Department of Neurology, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK.
Department of Neurology, Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK.
出版信息
J Neurol. 2022 Feb;269(2):1065-1067. doi: 10.1007/s00415-021-10927-6. Epub 2022 Jan 4.
Abstract
摘要
相似文献
1
Advances in the use of stem cell transplants in the treatment of multiple sclerosis.干细胞移植在多发性硬化症治疗中的应用进展。
J Neurol. 2022 Feb;269(2):1065-1067. doi: 10.1007/s00415-021-10927-6. Epub 2022 Jan 4.
2
Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO.造血干细胞移植应作为高度活跃型多发性硬化症的二线治疗方法——不。
Mult Scler. 2016 Sep;22(10):1260-3. doi: 10.1177/1352458516644341. Epub 2016 Jul 21.
3
Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - YES.造血干细胞移植应作为高度活动性多发性硬化症的二线治疗方法——是。
Mult Scler. 2016 Sep;22(10):1258-9. doi: 10.1177/1352458516654311. Epub 2016 Jul 21.
4
Intense immunosuppression and autologous hematopoietic stem cell transplantation for multiple sclerosis.强化免疫抑制与自体造血干细胞移植治疗多发性硬化症
Haematologica. 2003 Mar;88(3):244-5.
5
Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis.五个问题解答：自体造血干细胞移植治疗多发性硬化症的综述。
Neurotherapeutics. 2017 Oct;14(4):888-893. doi: 10.1007/s13311-017-0564-5.
6
Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective.多发性硬化症的自体造血干细胞移植：当前的观点。
Mult Scler. 2021 Feb;27(2):167-173. doi: 10.1177/1352458520917936. Epub 2020 May 4.
7
[Immunoablation and autologous hematopoietic stem cell transplantation (AHSCT) in multiple sclerosis].[免疫消融与自体造血干细胞移植（AHSCT）治疗多发性硬化症]
Rev Neurol (Paris). 2008 Mar;164(3):207-15. doi: 10.1016/j.neurol.2007.10.001. Epub 2008 Feb 20.
8
Autologous hematopoietic stem cell transplantation in multiple sclerosis: a global approval and availability review.多发性硬化症中的自体造血干细胞移植：全球批准情况与可及性综述
Bone Marrow Transplant. 2021 Jul;56(7):1754-1756. doi: 10.1038/s41409-021-01276-z. Epub 2021 Apr 6.
9
[Hematopoietic stem cell transplantation in MS. Justified, and if so, when?].[多发性硬化症中的造血干细胞移植。合理吗？如果合理，何时进行？]
Lakartidningen. 2006;103(9):640-2.
10
Autologous haematopoietic stem cell transplantation.自体造血干细胞移植
Neurol Sci. 2005 May;26 Suppl 1:S19. doi: 10.1007/s10072-005-0394-9.
引用本文的文献
1
Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure.新发现的多发性硬化症中枢神经系统缺陷及其对髓鞘再生失败的影响。
Biomedicines. 2022 Mar 30;10(4):815. doi: 10.3390/biomedicines10040815.
Zotero 插件